Evidence map›Paper›PMID 28274248›Full record

ArticleParasites & vectors2017

A Bayesian spatio-temporal model for forecasting the prevalence of antibodies to Ehrlichia species in domestic dogs within the contiguous United States.

Yan Liu, Robert B Lund, Shila K Nordone, Michael J Yabsley, Christopher S McMahan

Open access · goldAbstract read
In one paragraph

Article in Parasites & vectors, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Ecological and Socioeconomic Factors Associated withVector borne and zoonotic diseases (Larchmont, N.Y.) · 2019
    Article
  8. Article
  9. Spatio-Temporal Analysis of Suicide-Related Emergency Calls.International journal of environmental research and public health · 2017
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Yan LiuDepartment of Mathematical Sciences, Clemson University, Clemson, SC, USA.
Robert B LundDepartment of Mathematical Sciences, Clemson University, Clemson, SC, USA.
Shila K NordoneDepartment of Molecular and Biomedical Sciences, Comparative Medicine Institute, North Carolina State University, Raleigh, NC, USA.
Michael J YabsleyDepartment of Population Health, Southeastern Cooperative Wildlife Disease Study, College of Veterinary Medicine and the Warnell School of Forestry and Natural Resources, The University of Georgia, Athens, GA, USA. myabsley@uga.edu.
Christopher S McMahanDepartment of Mathematical Sciences, Clemson University, Clemson, SC, USA. mcmaha2@clemson.edu.
Clemson University · USNorth Carolina State University · USUniversity of Georgia · US

Funding

Group testing for infectious disease detection: multiplex assays and back-end screeningR01AI121351 · NIAID · UNIVERSITY OF NEBRASKA LINCOLN · PI BILDER, CHRISTOPHER R · 2016 to 2025
$3.3M
NIAID NIH HHS R01 AI121351
6 · The paper itself

Abstract

backgroundDogs in the United States are hosts to a diverse range of vector-borne pathogens, several of which are important zoonoses. This paper describes factors deemed to be significantly related to the prevalence of antibodies to Ehrlichia spp. in domestic dogs, including climatic conditions, geographical factors, and societal factors. These factors are used in concert with a spatio-temporal model to construct an annual seroprevalence forecast. The proposed method of forecasting and an assessment of its fidelity are described.

methodsApproximately twelve million serological test results for canine exposure to Ehrlichia spp. were used in the development of a Bayesian approach to forecast canine infection. Data used were collected on the county level across the contiguous United States from routine veterinary diagnostic tests between 2011-2015. Maps depicting the spatial baseline Ehrlichia spp. prevalence were constructed using Kriging and head-banging smoothing methods. Data were statistically analyzed to identify factors related to antibody prevalence via a Bayesian spatio-temporal conditional autoregressive (CAR) model. Finally, a forecast of future Ehrlichia seroprevalence was constructed based on the proposed model using county-level data on five predictive factors identified at a workshop hosted by the Companion Animal Parasite Council and published in 2014: annual temperature, percentage forest coverage, percentage surface water coverage, population density and median household income. Data were statistically analyzed to identify factors related to disease prevalence via a Bayesian spatio-temporal model. The fitted model and factor extrapolations were then used to forecast the regional seroprevalence for 2016.

resultsThe correlation between the observed and model-estimated county-by-county Ehrlichia seroprevalence for the five-year period 2011-2015 is 0.842, demonstrating reasonable model accuracy. The weighted correlation (acknowledging unequal sample sizes) between 2015 observed and forecasted county-by-county Ehrlichia seroprevalence is 0.970, demonstrating that Ehrlichia seroprevalence can be forecasted accurately.

conclusionsThe forecast presented herein can be an a priori alert to veterinarians regarding areas expected to see expansion of Ehrlichia beyond the accepted endemic range, or in some regions a dynamic change from historical average prevalence. Moreover, this forecast could potentially serve as a surveillance tool for human health and prove useful for forecasting other vector-borne diseases.

Indexed as

Bayes TheoremAnimalsDog DiseasesDogsEhrlichiaEhrlichiosisModels, BiologicalSeroepidemiologic StudiesUnited StatesAutoregressionCAR ModelEhrlichiosisHead-bangingKrigingPrevalenceSpatio-temporal modeling

Identifiers

PMID28274248
PMCPMC5343545
OpenAlexW2592033118

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.